Raju Prasad - Oct 16, 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Financial Officer
Signature: /s/ Elizabeth Ryland Waldinger, attorney-in-fact
Stock symbol: CRSP
Transactions as of: Oct 16, 2024
Transactions value $: $0
Form type: 4
Date filed: 10/18/2024, 05:35 PM
Previous filing: Mar 22, 2024
Next filing: Mar 18, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Award	$0	+18.3K		$0.00	18.3K	Oct 16, 2024	Common Shares	18.3K	$49.00	Direct	F1
transaction	CRSP	Restricted Stock Units	Award	$0	+15K		$0.00	15K	Oct 16, 2024	Common Shares	15K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of on November 16, 2024.
F2	Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F3	This restricted stock unit award was granted on October 16, 2024 with respect to 15,000 Common Shares, with 100% of the shares vesting on October 16, 2027.